| 摘要 |
The invention relates to a solid pharmaceutical formulation containing licofelone or a physiologically acceptable salt thereof and at least one water soluble polymer selected from the group containing hydroxyalkyle celluloses, methyl cellulose, polyvinyl pyrrolidones and copolymers thereof, polyvinyl alcohols, saponified or partially saponified copolymers of N-vinyl pyrrolidone and vinyl esters, and/or at least one water soluble polyol selected from polyethylene glycols having a molecular weight in the region of 8.000 - 20.000 and sugar alcohols. The invention also relates to a formulation which releases the active ingredient in a rapid manner. |
